Work

Targeting 14-3-3 sensitizes native and mutant BCR-ABL to inhibition with U0126, rapamycin and Bcl-2 inhibitor GX15-070

Year: 2007

Type: article

Source: Leukemia

DOI: 10.1038/sj.leu.2405064

Authors: S Dong, S Kang, S Lonial, H J Khoury, J Viallet, J Chen

Institutions: Emory University, Winship Cancer Institute, Concordia University

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Georgia Cancer Coalition, National Institutes of Health, National Cancer Institute

Awards: Signaling and targeting of FGFR1 fusions in 8p11 myeloproliferative syndrome, G970688876

OpenAlex ID: W1995160625

FWCI: 2.447

Cites: 15

Cited by: 37

Related to: 10